New comment by Medical Oncologist at The Ohio State University Comprehensive Cancer Center / James Cancer Hospital and Solove Research Institute ( May 8, 2025)
Response to the targeted therapy, like hedgehog inhibitors, does not have the long-term durable response you see with immune checkpoint therapy. Even if you achieve a pCR with...